| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2012 | WO2011112071A3 Synergistic effect of tocotrienols and curcumin |
| 01/05/2012 | WO2011109743A3 Synergistic effects of combinations of buprenorphine and opioids for the treatment of pain |
| 01/05/2012 | WO2011108821A3 Composition for suppressing aging skin or reducing skin wrinkles, containing dalbergia odorifera extract, fraction thereof or compound separated therefrom as active ingredient |
| 01/05/2012 | WO2011107970A3 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
| 01/05/2012 | WO2011107877A3 Compounds and compositions and their use in the treatment of diseases related to copper retention |
| 01/05/2012 | WO2011107870A3 Compounds and compositions and their use in the treatment of diseases related to copper retention |
| 01/05/2012 | WO2011106248A3 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 01/05/2012 | WO2011103345A3 Methods and compositions for influencing tumors using microrna-185 as a tumor suppressor |
| 01/05/2012 | WO2011103175A3 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling |
| 01/05/2012 | WO2011103007A3 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells |
| 01/05/2012 | WO2011099804A3 Novel antifungal triazole derivatives |
| 01/05/2012 | WO2011099764A3 Novel pyrimidine derivative for inhibiting the growth of cancer cells |
| 01/05/2012 | WO2011097221A3 Methods of promoting tissue growth and tissue regeneration |
| 01/05/2012 | WO2011096688A3 Composition for improving scalp and hair health comprising a dibenzo-p-dioxin derivative |
| 01/05/2012 | WO2011096665A3 Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor |
| 01/05/2012 | WO2011094598A3 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 01/05/2012 | WO2011094545A3 Compositions and methods for enhancing proteasome activity |
| 01/05/2012 | WO2011093672A3 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase |
| 01/05/2012 | WO2011093664A3 Anti-obesity composition containing (1s,2s,3s,4s)-5-aminocyclopentane-1,2,3,4-tetraol |
| 01/05/2012 | WO2011093647A3 Genes implicated in osteoarthritis and use thereof |
| 01/05/2012 | WO2011091167A3 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 01/05/2012 | WO2011090317A3 Imidazopyrazinone derivatives with apoptosis inducing activity on cells |
| 01/05/2012 | WO2011067667A3 Fexofenadine microcapsules and compositions containing them |
| 01/05/2012 | WO2011061330A9 Use of physiological cooling active ingredients, and agents containing such active ingredients |
| 01/05/2012 | WO2011045760A3 Micronized olmesartan medoxomil compositions |
| 01/05/2012 | WO2011044538A9 Antibacterial aminoglycoside analogs |
| 01/05/2012 | WO2011033021A3 Improved purification of multi-specific receptors |
| 01/05/2012 | WO2011010070A3 Insecticide and/or repellent method |
| 01/05/2012 | WO2010139180A8 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 01/05/2012 | WO2010134846A8 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same |
| 01/05/2012 | WO2010133377A8 Fat blends and uses thereof |
| 01/05/2012 | WO2010089753A3 Novel polymorphs of lopinavir |
| 01/05/2012 | US20120005777 Process for the Production of Fine Chemicals |
| 01/05/2012 | US20120005128 Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation |
| 01/05/2012 | US20120004593 Antiseptic based on bispyridinium alkanes |
| 01/05/2012 | US20120004592 Compositions for solubilizing tissue |
| 01/05/2012 | US20120004428 Tri-Substituted 2-Benzhydryl-5-Benzylamino-Tetrahydro-Pyran-4-OL and 6-Benzhydryl-4-Benzylamino-Tetrahydro-Pyran-3-OL Analogues, and Novel 3,6-Disubstituted Pyran Derivatives |
| 01/05/2012 | US20120004320 Method for Treating Ocular Demodex |
| 01/05/2012 | US20120004319 Process for producing carotenoid |
| 01/05/2012 | US20120004318 Modified release formulations of memantine oral dosage forms |
| 01/05/2012 | US20120004317 Tapentadol for use in the treatment of irritable bowel syndrome |
| 01/05/2012 | US20120004316 Treating impulse control disorders with catechol-o-methyl-transferase inhibitors |
| 01/05/2012 | US20120004315 Selective Estrogen Receptor Modulator |
| 01/05/2012 | US20120004314 Antimicrobial composition |
| 01/05/2012 | US20120004313 Crystalline form vi of agomelatine, preparation method and application thereof |
| 01/05/2012 | US20120004312 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004310 Non-peptide bdnf neurotrophin mimetics |
| 01/05/2012 | US20120004309 Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof |
| 01/05/2012 | US20120004308 Method for obtaining solid micro- or nanoparticles |
| 01/05/2012 | US20120004307 Oral treatment of digital ischemic lesions |
| 01/05/2012 | US20120004306 External preparation containing analgesic/anti-inflammatory agent |
| 01/05/2012 | US20120004305 External preparation containing analgesic/anti-inflammatory agent |
| 01/05/2012 | US20120004304 Bile salt adjuvant for animals for improving fat utilization efficiency in the bodies of animals, and animal feed comprising same |
| 01/05/2012 | US20120004303 Method of dispensing a teething gel with a metered dose applicator |
| 01/05/2012 | US20120004301 Methods for treating restless legs syndrome |
| 01/05/2012 | US20120004300 Methods for treating bipolar disorder |
| 01/05/2012 | US20120004298 Ophthalmic devices containing chemokine antagonists |
| 01/05/2012 | US20120004297 Agent for alleviating vascular failure |
| 01/05/2012 | US20120004296 Chroman derivatives, medicaments and use in therapy |
| 01/05/2012 | US20120004295 Administration of 6'-ethyl lepimectin, 6'-methyl lepimectin or derivatives thereof for treating dermatological disorders in humans |
| 01/05/2012 | US20120004294 Antitumor combination combining ave8062 and docetaxel |
| 01/05/2012 | US20120004293 Cancer Cell Targeting Using Nanoparticles |
| 01/05/2012 | US20120004292 Composition for injection comprising an injection medicinal product and a gel |
| 01/05/2012 | US20120004291 Companion animal compositions including pyruvic acid and salts thereof and methods of use thereof |
| 01/05/2012 | US20120004290 Treating chronic fatigue syndrome and prolonged qt interval |
| 01/05/2012 | US20120004289 Annexin a11 and associated genes as biomarkers for cancer |
| 01/05/2012 | US20120004288 Compounds for the modulation of beta-catenin expression |
| 01/05/2012 | US20120004287 Therapeutic agent comprising vasohibin |
| 01/05/2012 | US20120004286 Long-acting veterinary polypeptides and methods of producing and administering same |
| 01/05/2012 | US20120004285 Erbb-3 (her3)-selective combination therapy |
| 01/05/2012 | US20120004284 Pdk inhibitor compounds and methods of use thereof |
| 01/05/2012 | US20120004283 Novel shrna gene therapy for treatment of ischemic heart disease |
| 01/05/2012 | US20120004282 RNA Interference Mediated Inhibition of the Intercellular Adhesion Molecule 1 (ICAM-1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/05/2012 | US20120004281 RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/05/2012 | US20120004280 RNA Interference Mediated Inhibition of the High Affinity 1 gE Receptor Alpha Chain (FC Epsilon R1 Alpha) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/05/2012 | US20120004279 Compositions and methods for modulating activity of capped small rnas |
| 01/05/2012 | US20120004278 Linc rnas in cancer diagnosis and treatment |
| 01/05/2012 | US20120004277 Vector(s) containing an inducible gene encoding a cdk4/cdk6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of the cell cycle |
| 01/05/2012 | US20120004276 Rna antagonist compounds for the inhibition of expression of mitochondrial glycerol-3 phosphate acyltransferase 1 (mtgpat1) |
| 01/05/2012 | US20120004275 Sceletium extract and uses thereof |
| 01/05/2012 | US20120004274 Use of inhibitors of jun n-terminal kinases to treat glaucoma |
| 01/05/2012 | US20120004273 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 01/05/2012 | US20120004272 Biocidal composition of 2,6-dimethyl-m-dioxane-4-ol acetate and methods of use |
| 01/05/2012 | US20120004271 Use of vaginally-administered insulin sensitizing agents |
| 01/05/2012 | US20120004270 Selective Androgen Receptor Modulators |
| 01/05/2012 | US20120004269 Alkynyl Phenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders |
| 01/05/2012 | US20120004267 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | US20120004266 Dopamine-beta-hydroxylase genetic polymorphism and migraine |
| 01/05/2012 | US20120004265 Ophthalmic Compositions and Methods of Using the Same |
| 01/05/2012 | US20120004264 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 01/05/2012 | US20120004263 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/05/2012 | US20120004262 Phenylcyclopropylamine derivatives and their medical use |
| 01/05/2012 | US20120004261 Mif modulators |
| 01/05/2012 | US20120004260 Inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds and methods of treatment thereof |
| 01/05/2012 | US20120004259 Method of treatment or prophylaxis |
| 01/05/2012 | US20120004258 Quinuclidine carbonate salts and medicinal composition thereof |
| 01/05/2012 | US20120004257 Novel compounds |
| 01/05/2012 | US20120004256 Parenteral formulation of clopidogrel |
| 01/05/2012 | US20120004255 Dual phase drug release system |